Earnings Call · Q3 FY2023·2023-11-14

Q3 23EPS n/a·Rev n/aQ2 23EPS n/a·Rev n/aQ1 23EPS n/a·Rev n/aQ4 22EPS n/a·Rev n/a⚠ consensus missing

TriSalus Life Sciences, Inc. TLSI

James Young — Senior Vice President of Investor Relations and Treasurer

Mary Szela — President and Chief Executive Officer

Sean Murphy — Chief Financial Officer

Steven Katz — Chief Medical Officer

Key highlights from the presentation include

−0.2%1d on move date−2.2% vs SPY3d−1.5%5d−7.0%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TLSI calls or request research access.

More TLSI calls Browse calls Request research access